Literature DB >> 23571092

Mutation of the dengue virus type 2 envelope protein heparan sulfate binding sites or the domain III lateral ridge blocks replication in Vero cells prior to membrane fusion.

John T Roehrig1, Siritorn Butrapet, Nathan M Liss, Susan L Bennett, Betty E Luy, Thomas Childers, Karen L Boroughs, Janae L Stovall, Amanda E Calvert, Carol D Blair, Claire Y-H Huang.   

Abstract

Using an infectious cDNA clone we engineered seven mutations in the putative heparan sulfate- and receptor-binding motifs of the envelope protein of dengue virus serotype 2, strain 16681. Four mutant viruses, KK122/123EE, E202K, G304K, and KKK305/307/310EEE, were recovered following transfection of C6/36 cells. A fifth mutant, KK291/295EE, was recovered from C6/36 cells with a compensatory E295V mutation. All mutants grew in and mediated fusion of virus-infected C6/36 cells, but three of the mutants, KK122/123EE, E202K, G304K, did not grow in Vero cells without further modification. Two Vero cell lethal mutants, KK291/295EV and KKK307/307/310EEE, failed to replicate in DC-SIGN-transformed Raji cells and did not react with monoclonal antibodies known to block DENV attachment to Vero cells. Additionally, both mutants were unable to initiate negative-strand vRNA synthesis in Vero cells by 72h post-infection, suggesting that the replication block occurred prior to virus-mediated membrane fusion. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23571092     DOI: 10.1016/j.virol.2013.03.011

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  23 in total

1.  Recovery of West Nile Virus Envelope Protein Domain III Chimeras with Altered Antigenicity and Mouse Virulence.

Authors:  Alexander J McAuley; Maricela Torres; Jessica A Plante; Claire Y-H Huang; Dennis A Bente; David W C Beasley
Journal:  J Virol       Date:  2016-04-14       Impact factor: 5.103

2.  Targeting domain-III hinging of dengue envelope (DENV-2) protein by MD simulations, docking and free energy calculations.

Authors:  Kshatresh Dutta Dubey; Gargi Tiwari; Rajendra Prasad Ojha
Journal:  J Mol Model       Date:  2017-03-02       Impact factor: 1.810

Review 3.  Mouse models of dengue virus infection for vaccine testing.

Authors:  Vanessa V Sarathy; Gregg N Milligan; Nigel Bourne; Alan D T Barrett
Journal:  Vaccine       Date:  2015-10-23       Impact factor: 3.641

4.  A Monoclonal Antibody Specific for Japanese Encephalitis Virus with High Neutralizing Capability for Inclusion as a Positive Control in Diagnostic Neutralization Tests.

Authors:  Amanda E Calvert; Susan L Bennett; Kandice L Dixon; Carol D Blair; John T Roehrig
Journal:  Am J Trop Med Hyg       Date:  2019-07       Impact factor: 2.345

5.  Near-atomic resolution cryo-electron microscopic structure of dengue serotype 4 virus.

Authors:  Victor A Kostyuchenko; Pau Ling Chew; Thiam-Seng Ng; Shee-Mei Lok
Journal:  J Virol       Date:  2013-10-23       Impact factor: 5.103

6.  Functional analysis of dengue virus (DENV) type 2 envelope protein domain 3 type-specific and DENV complex-reactive critical epitope residues.

Authors:  Trevor J Pitcher; Vanessa V Sarathy; Kiyohiko Matsui; Gregory D Gromowski; Claire Y-H Huang; Alan D T Barrett
Journal:  J Gen Virol       Date:  2014-10-22       Impact factor: 3.891

7.  Structure-based mutational analysis of several sites in the E protein: implications for understanding the entry mechanism of Japanese encephalitis virus.

Authors:  Haibin Liu; Yi Liu; Shaobo Wang; Yanjun Zhang; Xiangyang Zu; Zheng Zhou; Bo Zhang; Gengfu Xiao
Journal:  J Virol       Date:  2015-03-11       Impact factor: 5.103

8.  Molecular determinants of dengue virus 2 envelope protein important for virus entry in FcγRIIA-mediated antibody-dependent enhancement of infection.

Authors:  Nunya Chotiwan; John T Roehrig; Jacob J Schlesinger; Carol D Blair; Claire Y-H Huang
Journal:  Virology       Date:  2014-04-18       Impact factor: 3.616

Review 9.  Discovery of B-cell epitopes for development of dengue vaccines and antibody therapeutics.

Authors:  Mohd Ishtiaq Anasir; Chit Laa Poh
Journal:  Med Microbiol Immunol       Date:  2022-01-21       Impact factor: 3.402

Review 10.  The key amino acids of E protein involved in early flavivirus infection: viral entry.

Authors:  Tao Hu; Zhen Wu; Shaoxiong Wu; Shun Chen; Anchun Cheng
Journal:  Virol J       Date:  2021-07-03       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.